{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-036768","form_type":"8-K/A","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.915320+00:00","generated_at":"2026-06-10T02:28:47.040044+00:00","sec_items":["4.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Oncocyte completes engagement of Marcum LLP as independent auditor for FY2023","bullets":["Marcum LLP completed client acceptance procedures on October 10, 2023, satisfying the condition noted in the original 8-K.","Marcum provided a fully executed engagement letter, formalizing its appointment as auditor for FY2023.","No other changes from the previously reported auditor change; this amendment solely confirms the completion of the engagement process."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-036768","json":"https://secwatch.observer/filing/0001493152-23-036768.json","markdown":"https://secwatch.observer/filing/0001493152-23-036768.md","text":"https://secwatch.observer/filing/0001493152-23-036768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223036768/0001493152-23-036768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223036768/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:28:47.040044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d2772e25e842e61a1c0c4230acc08f41f53730a","claim":"Insight Molecular Diagnostics Inc. engaged Marcum LLP as its auditor.","evidence_excerpt":"the Company is filing this amendment to the above-referenced Form 8-K to disclose that on October 10, 2023, Marcum completed its client acceptance procedures and provided the Company with a fully executed engagement letter.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223036768/0001493152-23-036768-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Marcum LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}